Henry Ford Hospital Medical Journal
Volume 37

Number 3

Article 30

9-1989

A Novel Parathyroid Hormone-Related Gene Product
T. J. Martin
J. A. Danks

Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons

Recommended Citation
Martin, T. J. and Danks, J. A. (1989) "A Novel Parathyroid Hormone-Related Gene Product," Henry Ford
Hospital Medical Journal : Vol. 37 : No. 3 , 187-189.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol37/iss3/30

This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health
System Scholarly Commons.

A Novel Parathyroid Hormone-Related Gene Product
T.J. Martin,* and J.A. Danks*

A parathyroid hormone-related protein (PTHrP) has been invoked as being responsible for the
humoral hypercalcemia of malignancy. Eight of the first 13 amino acids of PTHrP are identical with
those in PTH, hut there is no other significant homology. The PTHrP gene is located on chromosome
12, whereas that for PTH is on chromosome II, and lhe two genes are probably related by a
duplication process. Anlisera against PTHrP( 1-34), which cross-read poorly or not at all with PTH,
and anlisera againsl olher parts of PTHrP nol homologous to PTH were used in immunocytochemistry, using a peroxidase-antiperoxidase melhod, lo idenlify PTHrP in the cytoplasm of cells
in a series of unselecledparathyroid adenomata. The study was based on our evidence that PTHrP is
produced by fetal parathyroid and may be the predominant calcium-regulating hormone in the
mammalian fetus. Glands from five patients wilh parathyroid hyperplasia secondary to chronic renal
failure also stained positively for PTHrP. No evidence was obtained for PTHrP in sections from five
patients with primary parathyroid chief cell hyperplasia or in a small group of patients with the
muUiple endocrine neoplasia type 1 or type 2 syndromes. (Henry Ford Hosp MedJ 1989:37:187-9)

H

umoral hypercalcemia of malignancy, a common syndrome in patients with cancer, is thought to be due to the
elaboration by the tumor of factor(s) which act on bone to sfimulate resorption and on kidney to decrease calcium and increase
phosphoras excretion (I). Many common biochemical characteristics exist between humoral hypercalcemia of malignancy
and primary hyperparathyroidism. Since clinical evidence and
preliminary radioimmunoassays suggested that the responsible
factor was similar to parathyroid hormone (PTH), the search began to identify the PTH-Iike agent responsible for humoral hypercalcemia of malignancy. The search ended in 1987 with the
purification, cloning, sequencing, and expression of a previously unrecognized PTH-related protein (PTHrP) (2-4).

Characterization of PTHrP
Purification of PTHrP was achieved from conditioned medium produced by a lung cancer cell line (BEN) originally derived from a patient with squamous cell carcinoma of the lung
associated with hypercalcemia (2). Amino-terminal sequence
information led to-the cloning of PTHrP cDNA (3) and predicfion of a protein of 141 amino acids, including a 36 amino acid
prepro-sequence.
PTHrP resembles PTH in many of its biological actions in that
it stimulates cAMP producfion only in PTH target tissues and
this action is prevented by antagonists of PTH. PTHrP is immunologically distinct from PTH since antisera against PTH,
which completely inhibit the biological effects of PTH, have no
effect on the acfivity of PTHrP (5,6).
The limited homology at the amino-terminal region of the
mature protein (eight of the first 13 identical) between PTHrP
and PTH is sufficient to account for the interaction of PTHrP
with the PTH receptor since the amino-terminal region of PTH
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interacts with the PTH receptor Studies with recombinant
PTHrP(l-14t), PTHrP( 1-108), and PTHrP(t-84) have shown that
each of these proteins has PTH-Iike actions similar to those of
the synthetic PTHrP peptidesfirststudied (5). Furthermore, on a
molar basis, each of the longer preparations of PTHrP is equipotent with PTHrP(l-34) in activating adenylate cyclase in PTH
responsive cells (5). Therefore, as is the case with PTH, the major actions of PTHrP on kidney and bone are carried out by the
amino-terminal portion of the molecule within the first 34 amino
acids.

Human PTHrP Gene
PTHrP cDNA clones have also been isolated from libraries
derived from two human renal cett carcinoma celt tines and have
been shown to contain essentially the same PTHrP coding sequence (4,5). However, the cDNAs differed in that they contained divergent carboxyterminal coding regions and 5'- and 3'untranslated regions. This suggested that alternatively spliced
mRNAs produce multiple cDNA species encoding PTHrP. This
was confirmed when the PTHrP gene was cloned (8,9), revealing a gene stracture more complex than that of PTH. The PTHrP
gene is located on chromosome 12 (4,8) whereas that for PTH is
on chromosome 11. With the PTHrP gene, attemate promoters
produce muttiple mRNA species with different 5'-untranslated
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Thus it seemed likety that PTHrP is the hormone of the fetal
parathyroid responsibte for maintaining extracellular fluid calcium in the fetus by the onty means available to it—tbe placental
calcium pump. The realization that PTHrP is indeed likety to be
a parathyroid hormone ted to two further lines of investigation.
First, a clonal rat parathyroid cell line thought to produce PTH
was shown to produce predominantly, or even exclusively,
PTHrP and to release into medium a form equivalent in size to
PTHrP(l-84) (13). Second, immunohistology was used to investigate the possibility that PTHrP is produced by abnormal parathyroid fissue.

PTHrP in Parathyroid Adenoma and Hyperplasia
Figure—A parathyroid adenoma from a patient with primary hyperparathyroidism showing positive staining for
PTHrP( 1-34) in the adenomatous tissue but no staining in the
rim of normal parathyroid tissue (arrow) (immunoperoxidase
staining method).

regions which encode the same protein. However, variable splicing at the 3' end results in different lengths of the mature protein.
The biological or functional significance of these altemate Cterminal sequences is cunentiy unknown. Whether or not any of
these forms conespond to the final secretory form of the protein
orto the normal circulating form of PTHrP is also unknown. The
potential for tissue-specific gene expression implicit in the existence of alternate promoter regions is an interesting aspect of
PTHrP gene regulation.

Physiological Functions of PTHrP
It is clear that PTHrP is a previously unrecognized hormone.
It has been localized by immunohistology in the spinous keratinocyte layer of normal skin and in 100% of a variety of unselected squamous cett cancers (6). PTHrP appears to be a
marker of epithelial cells but is not exclusively confined to them,
since it is produced atso by the celts of adult T-cell leukemia associated with the retrovims human T-lymphotropic vims type 1
(10) . In the skin PTHrP may have a local function in differentiation of keratinocytes, but this remains to be detennined.
Before the stracture of PTHrP was known, we considered that
it might be a fetal form of PTH and obtained evidence for the
production of PTHrP by ovine placenta and fetal parathyroid
(11,12). Extracellular fluid calcium levels in the mammalian
fetus are maintained by an active pump of calcium from mother
to fetus, making calcium available for the growing fetal skeleton
(11) . Experiments were carried out in which placentae were perfused at the end of pregnancy in ewes whose fetuses had been
parathyroidectomized several weeks earlier (11). In these circumstances the active calcium pump in the placenta is greatiy
reduced. We showed that it could be restored by partially or
highly purified PTHrP (11) and by recombinant PTHrP but not
by PTH or by PTHrP(l-34). Evidence clearly showed that the
fetal parathyroid gland is a source of PTHrP (12).
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Primary hyperparathyroidism is usually associated with an
adenoma and tess commonly with chief celt hyperplasia invotving muttiple parathyroid glands. Hyperplasia is also a feature of
the muttiple endocrine neoplasia (MEN) type 1 and type 2 syndromes, tn an immunohistochemical study, we used antibodies
directed against various sequences of PTHrP to establish the
presence of the antigen in adenomata and in hyperplastic glands
from patients with primary hyperparathyroidism and with hyperparathyroidism secondary to chronic renal disease.
Polyclonal anrisera against synthetic peptides PTHrP(t-34),
PTHrP(50-69), and PTHrP(t06-t4t) were used in a peroxidaseantiperoxidase technique on paraffin sections which has been
described in detaU (6). The anti-PTHrP(l-34) antisera used in att
studies were chosen carefully for lack of any demonstrable
cross-reaction against PTH(l-34) even at the very high concentrations used in neutralizing biological activity (6).
Fourteen patients with adenomatous primary hyperparathyroidism had tumors that showed strongly positive staining
with anti-PTHrP(l-34) and anti-PTHrP(50-69) but not with antiPTHrP(t06-t4t). An example is shown in the Figure, which illustrates the lack of staining in the sunounding nonneoplastic
parathyroid tissue. Of sections examined fromfivepatients with
primary hyperparathyroidism due to hyperplasia, four were
negative with att three antisera, and one was faintly positive with
anti-PTHrP(t-34). In parathyroid hyperplasia secondary to
chronic renal failure, however, the sections of alt five patients
stained positively with anti-PTHrP(t-34) and anti-PTHrP(50-69).
Sections were atso examined from four patients with MEN 1
(provided by Dr J. Shepherd, Hobart, Tasmania) and from two
patients with MEN 2A (provided by Dr N. Samaan, Houston,
TX). Att these sections were negative with att antisera.
It is concluded that parathyroid adenoma and secondary hyperplastic glands from ctironic renal failure patients are capable
of producing PTHrP. To what extent the protein reaches the circulation in these conditions, and how PTHrP might contribute to
the disorders of calcium metabolism in these states, if at alt, remains unknown. In this study, the PTH levets were elevated in
those pafients who were assayed (14).
Failure to find evidence of PTHrP in tissue from primary hyperplasia is surprising. The stimulus of hypercalcemia in
chronic renal failure seemed sufficient to provoke PTHrP production. Whatever the stimulus to polyclonal expansion in primary hyperplasia, it might be expected that the same cellular
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process woutd occur as in secondary hyperparathyroidism. In
MEN I , a humoral factor is proposed as the stimulus to the parathyroid (15), and it is possibte that analogous factors operate in
primary hyperplasia and MEN 2. It woutd certainty be of interest if any stimulus to hyperplasia in these conditions resutted in
selective overproduction of PTH but not of PTHrP, whereas in
chronic renal failure as a cause of hyperplasia both peptides are
produced.
Failure of the carboxyterminal antiseram to detect PTHrP in
adenomatous or secondary hyperplastic parathyroid glands is
also of interest. The same anti-PTHrP(t06-141) anfiseram readily detects PTHrP in the spinous keratinocyte layer of normal
skin (14). The finding might indicate that a processing mechanism operates in the parathyroid cett, resutting in cleavage of a
carboxyterminal fragment, and that this either does not take
place in skin or does so to a much lesser extent. It may be relevant that a clonal nontransformed rat parathyroid cett tine secretes PTHrP equivalent in size to PTHrP(l-84), with no larger
materiat detectable (13).
Thefindingswith immunohistology complement the observations of Ikeda et at (16) who demonstrated expression of mRNA
for PTHrP in seven of eight parathyroid adenomata and in the
only patient they examined who had chronic renal failure with
secondary hyperparathyroidism. They did not examine tissue
from primary hyperplastic glands. The genes for MEN 1 and
MEN 2 are linked to chromosome 11 and to chromosome 10, respectivety. The growth factor thought to be important in MEN 1
is probably not so in MEN 2 or idiopathic primary hyperplasia.
Although the hyperplastic stimulus of chronic renal failure resutts in identifiable producfion of PTHrP by the parathyroid, this
does not occur in any of the primary hyperplastic syndromes.
Further studies of PTHrP production and secretion by abnormal parathyroid tissue witl be of interest, particularly for understanding the molecular mechanisms of the MEN syndromes.
Although early data from analysis of glucose-6-phosphate
dehydrogenase isoenzyme in parathyroid tumors indicated that
adenomata were multicellular in origin (17), a recent molecular
approach suggests that most parathyroid adenomata have a
monoclonal origin (18). In the MEN syndromes, hyperplasia
precedes tumor fonnation. Our identificafion of PTHrP in adenomatous and in renal failure glands but not in those from primary hyperplasia or MEN patients might be due to differing
amounts of hormone present in those circumstances or could imply fundamental differences in pathogenesis. Plasma assays of
sufficient sensitivity and specificity will be necessary to assess
the role of PTHrP in hyperparathyroid syndromes.
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